Find the right psychiatrist for your needs

Dr. Illise Perlmutter is the Director of Child and Adolescent Psychiatry at Talkiatry. She is double board-certified in child and adolescent psychiatry and adult psychiatry. Before joining Talkiatry, Dr. Perlmutter was the Chair of Behavioral Health and Addiction Services at Bergen New Bridge Medical Center. Prior to Bergen New Bridge, she was the Director of Inpatient Psychiatry at Montefiore Medical Center-Wakefield, in New York. Over 35 years, Dr. Perlmutter has held numerous leadership roles with some of the largest hospital systems in the New York Metro Area. Dr. Perlmutter is a Distinguished Life Fellow of the American Psychiatric Association, a Fellow of the American College of Psychiatrists, and a Distinguished Fellow of the American Academy of Child and Adolescent Psychiatry. She has received awards for her contributions both locally and nationally. Dr. Perlmutter was included in Castle Connolly's "America's Top Doctors” list from 2006-2011 and 2017, as well as "Best Doctors in America” from 2009- 2012. Dr. Perlmutter received her MD from George Washington University School of Medicine and Health Sciences. After an internship in pediatrics, she completed a residency in Psychiatry at Mt. Sinai Medical Center followed by a fellowship in Child and Adolescent Psychiatry at Columbia University/New York State Psychiatric Institute. Dr. Perlmutter has held leadership roles in several academic institutions and is a Clinical Associate Professor of Psychiatry and Behavioral Science at George Washington University School of Medicine and Health Sciences in Washington, D.C. Dr. Perlmutter has authored numerous publications and research articles and has lectured and presented extensively on clinical, epidemiologic, and psychopharmacologic issues in child and adolescent psychiatry. She has made frequent media appearances addressing topical issues in disaster psychiatry during the course of her work in disaster psychiatry outreach.

Dr. Georgia Gaveras holds the position of Co-Founder and Chief Medical Officer at Talkiatry. She is triple board-certified in child and adolescent psychiatry, adult psychiatry, and addiction medicine. She has been practicing for over 18 years. Dr. Gaveras's practice focuses on medication management. Typically, she offers this in conjunction with supportive or emotionally focused therapy in 30-minute follow-up visits. However, occasionally Dr. Gaveras may believe that additional therapy is also needed and ask that you bring a therapist into your care team to provide the best outcome. She received her medical degree from the University of New England College of Osteopathic Medicine in Biddeford, ME, before moving back to NY to complete her residency at the SUNY Downstate Medical Center and a fellowship in child and adolescent psychiatry at St. Luke's-Roosevelt Hospital. After completing training, she remained and worked with dually-diagnosed adolescents at the Comprehensive Rehabilitation and Education Service (CARES) before becoming the Director of Training and Education for the Mount Sinai St. Luke's and Roosevelt Hospitals. She was then the associate director of child and adolescent emergency psychiatry at Cohen Children's Medical Center before becoming the Director of the Comprehensive Psychiatric Emergency Program (CPEP) at Kings County Hospital in Brooklyn. Dr. Gaveras has held academic appointments at Columbia University College of Physicians and Surgeons, Mount Sinai Icahn School of Medicine, Touro College of Osteopathic Medicine, Zucker School of Medicine, and SUNY Downstate Medical College. In addition, she has appeared in numerous professional publications and authored several research papers. In addition to general, child, and adolescent psychiatry, Dr. Gaveras is also board-certified in addiction medicine and trained in the Eating Disorders, Compulsions and Addictions Service (EDCAS) program at the William Alanson White Institute. She completed her undergraduate studies at New York University. While having treated a wide variety of patients, her primary clinical focus has been in treating adolescents and young adults with co-occurring substance use disorders.